HANNAH FOWLER: Open Payments
NPI 1063282572 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 54 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,422 · 2025 $1,113
Food & beverage: $1,028Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $352 |
| Janssen Biotech, Inc. | 8 | $239 |
| PFIZER INC. | 6 | $137 |
| Ardelyx, Inc. | 5 | $105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| Madrigal Pharmaceuticals | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| EVOKE PHARMA, INC. | 1 | $20 |
Products named: RINVOQ, TREMFYA, XELJANZ, IBSRELA, XIFAXAN, SKYRIZI, REZDIFFRA, VELSIPITY.
Industry payments across GA — which companies pay providers there.
